SEC 13F Intelligence

S&Co Inc / BSX

S&Co Inc’s Boston Scientific Corp Position

Does S&Co Inc own Boston Scientific Corp (BSX)? Yes — 169.8K shares worth $11M (+0.66% of its 13F portfolio) as of Q1 2026, down from 170.9K shares the prior filed quarter.

Position Value
$11M
Q1 2026
Shares
169.8K
% of Portfolio
+0.66%
Quarters Held
27
currently held

Position History BSX

Reported value by quarter
Q1 ’19: $7MQ1 ’19Q2 ’19: $8MQ3 ’19: $7MQ4 ’19: $8MQ1 ’20: $6MQ1 ’20Q4 ’20: $6MQ1 ’21: $7MQ2 ’21: $7MQ3 ’21: $7MQ3 ’21Q4 ’21: $7MQ1 ’22: $8MQ2 ’22: $6MQ3 ’22: $7MQ3 ’22Q4 ’22: $8MQ1 ’23: $8MQ2 ’23: $9MQ3 ’23: $9MQ3 ’23Q4 ’23: $10MQ1 ’24: $11MQ2 ’24: $13MQ3 ’24: $14MQ3 ’24Q4 ’24: $14MQ1 ’25: $18MQ2 ’25: $19MQ3 ’25: $17MQ3 ’25Q4 ’25: $16MQ1 ’26: $11Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026169.8K$11M+0.66%
Q4 2025170.9K$16M+1.01%
Q3 2025173.3K$17M+1.04%
Q2 2025176.8K$19M+1.22%
Q1 2025177.7K$18M+1.20%
Q4 2024161.1K$14M+0.98%
Q3 2024162.6K$14M+0.89%
Q2 2024162.8K$13M+0.87%
Q1 2024164.8K$11M+0.79%
Q4 2023165.4K$10M+0.73%
Q3 2023165.4K$9M+0.72%
Q2 2023165.7K$9M+0.72%
Q1 2023168.7K$8M+0.72%
Q4 2022168.7K$8M+0.68%
Q3 2022168.7K$7M+0.59%
Q2 2022169.9K$6M+0.53%
Q1 2022169.9K$8M+0.53%
Q4 2021170.0K$7M+0.51%
Q3 2021170.0K$7M+0.58%
Q2 2021170.0K$7M+0.57%
Q1 2021175.3K$7M+0.57%
Q4 2020175.3K$6M+0.56%
Q1 2020178.1K$6M+0.78%
Q4 2019178.2K$8M+0.84%
Q3 2019182.0K$7M+0.82%
Q2 2019184.6K$8M+0.87%
Q1 2019185.2K$7M+0.79%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See S&Co Inc’s full portfolio or all institutional holders of BSX.